Insufficient tools for bedside prediction of late-onset neonatal sepsis (LNS) initiated this study. The objective was to develop and validate a simple prediction-scoring model for LNS defined as culture-proven sepsis occurring 72 hours after birth.
INTRODUCTION
Neonatal sepsis necessitates prompt diagnosis and decision for treatment. A presumptive clinical diagnosis generally is made on the basis of clinical, laboratory, and risk factor criteria. Late-neonatal sepsis (LNS), occurring after 72 hours of age, may occur in a neonate who has had a prolonged hospitalization. In early-onset sepsis, criteria for diagnosis are relatively well established, 1 but such criteria cannot be used with LNS because of known differences in risk factors, clinical features, and causative pathogens. 2 Few clinical scoring methods for the prediction of LNS have been developed, and they were mainly from the data of the neonates who had been worked-up as suspected sepsis. [3] [4] [5] The objectives of this study were to develop a practical, clinical prediction-scoring model for the diagnosis of LNS, and to validate the diagnostic performance of the model.
METHODS
The study was performed during 1998 to 2003 in four neonatology wards (two regular nurseries of postpartum wards, a 35-bed special care nursery, and a six-bed neonatal intensive care unit) of Ramathibodi hospital, a university hospital in Bangkok. The average annual delivery rate was about 7000 live births and the cesarean delivery rate was 32 to 40% during the study period. The neonates in each of the wards were cared for by a neonatology team consisting of an experienced neonatologist, one to two neonatology fellows, three pediatric residents, and neonatology nurses. All neonates having clinical signs or symptoms suggestive of neonatal sepsis underwent laboratory investigations including complete blood count (CBC), blood culture, urine culture, and cerebrospinal fluid examination or chest radiography when it was indicated. The protocol was approved by the Ethics Review Board of the Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. The study was divided into two phases: derivation and validation phases.
The derivation phase was a retrospective cohort study using medical records of neonates who were born at Ramathibodi Hospital during 1998 to 2000, and were hospitalized for >72 hours. The cohort was followed up from birth until they were discharged from hospital or dead, whichever occurred first. Of 21,455 neonates who were born during the study period, 9347 (44%) were hospitalized for >72 hours; 20% (1870/9347) of these neonates were enrolled by random selection using a computergenerated scheme. A neonate was excluded if suffering from a congenital anomaly which was incompatible with life. With this sample size, we had 84% power of test and 5% of type one error. The medical records including demographic data, possible risk factors, relevant laboratory data, and clinical signs and symptoms on the day of sepsis workup were reviewed. A neonate who also had early-onset sepsis would be included if the suspected LNS started at least 7 days after cessation of antimicrobial therapy. Sepsis was defined as the presence of one or more clinical signs suggestive of neonatal clinical sepsis, plus a positive culture for bacteria from a clinical specimen obtained from any normally sterile site (blood, cerebrospinal fluid, pleural fluid, and bone and joint), or a positive urine culture (collected by suprapubic tapping or urinary catherization, with single bacterial isolate of >10 5 colony-forming units/ml). The diagnosis of coagulase-negative staphylococcus bacteremia required two positive blood culture specimens of the same organism, either from a central venous catheter and a peripheral vein or from two separate peripheral venipunctures. Only the first episode of LNS in each neonate was considered. Manroe's reference values for neonatal white blood cell (WBC) counts 6 were used in defining abnormal WBC values. For the neonates without suspected LNS, we presumed that their clinical signs, symptoms, and laboratory data such as CBC were normal. Creactive protein (CRP) measurement was not routinely performed for neonatal septic evaluation in our hospital.
The validation phase was a cohort design with retrospective data collection. This phase included neonates who were born in the same hospital, >72 hours old, suspected of sepsis during July 2002 to June 2003. The prediction scoresFobtained from the derivation phaseFwere validated in this group of neonates.
Statistical Analysis
In the derivation phase, univariate analysis using Cox's proportional hazards regression model was applied to identify the potential prediction variables associated with LNS in all of the included neonates. The unit of analysis, person-days, was the time between 72 hours after birth and the onset of suspected sepsis, or discharge or death. Any variables that had p-value of <0.1 were simultaneously included in the multivariate Cox's model. Backward stepwise technique was used to select the most parsimonious model. The prediction variables independently associated with LNS were identified from the model. A score was assigned to each variable based on its rounded-up regression coefficient in the model. 7 The total prediction score for LNS of each neonate was the sum of variables' scores, and receiver operating characteristic (ROC) curve analysis was then used to evaluate the prediction performance. An area under the ROC curve (AUC) for each of the two phases was obtained and compared. Probability of LNS at a given prediction score of both sets of neonates suspected of LNS was estimated by logistic regression analysis. Probability of LNS in each group of neonates having a range of prediction scores was a rounded-up value of mean probability of LNS in that group. All analysis was performed using Stata 8.0 (StataCorp LP, College Station, TX, USA). A two-tailed p-value of <0.05 was considered as statistical significance in the final models.
RESULTS
Of 1870 randomly selected medical records of neonates who were hospitalized for >72 hours, 1824 (97%) were available for LNS prediction score derivation. Distributions of birth weight and gender of the study sample are not statistically different from the total study population (p ¼ 0.196 and 0.183). In all, 100 of the 1824 neonates had suspected LNS and laboratory investigations for sepsis, 17 of them had bacterial culture-proven LNS. Median (range) age of the 17 neonates at the onset of LNS was seven (range 3 to 24) days.
The incidence density of LNS was 17/11355 person-days or 1.5 (95% confidence interval (CI): 0.9 to 2.4) per 1000 person-days. Conditions of infections among the neonates who had LNS included simple bacteremia, nine; catheter-related bacteremia, four; urinary tract infections, three; and meningitis, one. Causative agents for bacteremia were, coagulase-negative staphylococci, eight; Staphylococcus aureus, two; Bacillus cereus, two; and Acinitobacter calcoaceticus, one. Escherichia coli caused urinary tract infection in two neonates; and Enterobacter cloacae,one. Streptococcus faecalis caused meningitis in one neonate. Table 1 presents incidence density of LNS and hazard ratios (HR) by potential risk variables in 1824 neonates. In total, 20 variables associated with proven LNS in univariate analysis were included in Cox's proportional hazards model; they were: (1) pregnancy and delivery conditions, one (gestational age of r34 weeks, and use of prenatal corticosteroids); (2) neonatal comorbidities, three (birth weight r1500 g, necrotizing enterocolitis, bronchopulmonary dysplasia); (3) clinical signs and symptoms, six (hypotension, lethargy, abnormal body temperature, mottling, respiratory insufficiency, feeding problems); and (4) hematologic findings, four (abnormal WBC, abnormal neutrophil counts, neutrophil band form fraction >1%, platelet count <150 Â 10 3 /ml); and (5) management variables, five (use of postnatal corticosteroids, ventilation support, umbilical artery catheter (UAC), umbilical vein catheter (UVC); and parenteral nutrition therapy). 'Gestational age r34 weeks' was forced into the model because of its general perception as a clinical significant predictor for neonatal sepsis.
Seven prediction variables could significantly explain LNS and were retained in the final Cox's proportional hazard model (Table 2) . Hypotension had the strongest association with LNS (HR, 56.4; 95% CI: 6.1 to 522.8), followed by abnormal body temperature (HR, 15.8; 95% CI 4.8 to 52.4). The presence of either respiratory insufficiency, lethargy, neutrophil bandemia, or of platelet counts <150 Â 10 3 /ml resulted in similar risk of LNS with point-estimated HR from 4.5 to 5.7. Duration of UVC usage had a dose-response relationship with LNS; a neonate who had been on UVC for 1 to 7 days or >7 days had 4.5 (95% CI:1 to 20) or 27.4 (95% CI: 6 to 126) times higher risk of LNS respectively, than a neonate without any UVC. The variable 'lethargy'Fwhich was generally measured subjectivelyFwas prone to invalid measurement and elimination of this variable did not change the AUC of the model, therefore 'lethargy' was eliminated from the model c . The total score of each neonate, which was the sum of the scores (derived from rounded-up coefficients) of the six variables that remained in the model, varied from 0 to 17 ( Table 2) .
Validation of the prediction-scoring model was performed in 73 neonates suspected for LNS. Of them, 44 (60%) neonates were male, 29 (40%) female, 38 (52%) were born vaginally, 35 (48%) by assisted delivery or cesarean section. Of 73 neonates, 51 (69%) were born at gestational age r34 weeks and 36/73 (49%) had a birth weight r1500 g; these were significantly different from the findings of neonates in the derivation phase (5% for rGA 34 weeks and 28% for birth weight r15000 g, p ¼ 0.01 and 0.05, respectively). The characteristics of neonates suspected for LNS were presented in Table 3 . In all, 25 of them (35%) had proven LNS (18/25 (72%) had bacteremia (coagulase-negtive staphylococci, six; Klebsiella pneumoniae, five; B. cereus, three; A. baumannii, two; Streptococcus groupD, one; Enterobacter spp, one), and 5/25 (20%) had UTI (E. coli, two; and K. pneumoniae, three)).
Prediction performance and probability of LNS at a given prediction score are presented in Table 4 . The AUCs were 0.85 (95% CI: 0.76 to 0.95) in derivation set and 0.80 (95% CI: 0.69 to 0.90) in validation set; w 2 , p ¼ 0.436. The best cutoff score in validation set was 4 where the prediction performance was: sensitivity 92% (95% CI: 71 to 98), specificity 56% (95% CI: 43 to 73), positive predictive value 56% (95% CI: 40 to 71), negative predictive value 90% (95% CI: 73 to 98), likelihood ratio positive 2.1, and likelihood ratio negative 0.14.
To simplify the prediction, the scores were grouped (Table 4 ) and the neonates were categorized into three risk groups for LNS as: (1) score from 0 to 3, low-risk group, approximate risk of LNS .10; (2) score from4 to 6, intermediate-risk group, risk 0.50; and (3) score Z7, high-risk group, risk 0.7. For example, a neonate who had fever, with hypotension, having neither respiratory insufficiency nor neutrophil band form, had a platelet count of 200 Â 10 3 /ml, and had been on UVC usage for 8 days, would have a prediction score of 11 (3 þ 4 þ 0 þ 0 þ 0 þ 4); he was therefore categorized in the high-risk group with an approximate risk of 0.70.
DISCUSSION
A scoring model for prediction of proven LNS was developed from clinical, laboratory, and management variables in a retrospective cohort of neonates being hospitalized >72 hours after birth at our hospital; and was then validated among a group of neonates suspected of LNS. The derived scoring model had a good predictability of proven LNS among neonates clinically suspected of LNS, and evaluation of the test in a validation setFalthough being different from the derivation set in gestational age and birth weightFresulted in similar prediction performance with AUCs of 0.85 and 0.80, respectively.
The incidence density of LNS in this study is considerably low (1.5/1000 person-days); an explanation is that only the neonates with culture-proven sepsis were diagnosed as having LNS in this study. Another explanation is that we only use first episodes of LNS to count for incidence of LNS. The previous reports, which were based on univariate analysis, suggested that lower birth weight and younger gestational age were associated with a higher risk of LNS. [8] [9] [10] [11] After adjustment for the effects of the other variables by multivariate analysis, we found that there was no significant association between LNS and potential risk variables such as: birth weight r1500 g, gestation age r34 weeks, prenatal corticosteroid therapy, major congenital anomalies, patent ductus arteriosus, bronchopulmonary dysplasia, necrotizing enterocolitis, usage of UAC or percutaneous central venous catheter, mechanical ventilation, or parenteral nutrition therapy. This study agrees with the previous reports [12] [13] [14] that duration of UVC usage was independently associated with the development of LNS.
Cox's proportional hazards analysis was used because it allows simultaneous adjustment for time-dependent predictors of LNS, and this approach seemed to be crucial for analysis of risk factors for LNS. 15 Rodwell et al 16 developed a scoring system by using seven hematological parameters as predictors, and four of them need differential WBC counts; but unreliability of differential WBC counts as being demonstrated by Schelonka 17, 18 would limit its usefulness. Singh et al 5 developed a prediction score for LNS based on clinical signs/symptoms. The study included both probable and culture-proven LNS in which the criteria for probable sepsis were not clearly described. In addition, lack of validation of the score seems to compromise validity of the study.
Mahieu et al 4 constructed and validated a Nosocomial Sepsis Prediction score (NOSEP score), which consisted of one clinical variable (fever, temperature >38.21C), three laboratory variables (C-reactive protein, Z14 mg/l; thrombocytopenia, platelet <150 Â 10 3 /ml; and neutrophil fraction, >50%), and 1 treatment variable (parenteral nutrition therapy, Z14 days). The internal validity of this score is good but its practical application is problematic. The majority of predictors by Mahieu et al 4 were based on laboratory data, which means that, in most circumstances, clinicians need to do CBC and CRP then wait for the results except only one situation; fever with parenteral nutrition >14 days. In contrast, our prediction score yields probability estimation for LNS primarily based on history and signs/symptoms that aid further clinical judgment at the bedside.
Compared to other prediction scores for LNS, this study included not only neonates with LNS suspicion, because including only specific group of patients would misestimate the effects of predictive parameters. The population at risk in our study was neonates who stayed in the hospital longer than 72 hours, not neonates with suspected LNS. In routine neonatal care, it is quite common that we care for some infants with multiple probable risk factors of developing LNS such as endotracheal intubation, mechanical ventilation, TPN, and UVC for weeks, and some of them may never be suspected of having LNS. Developing a prediction score without including these neonates will result in poor performance of prediction score in subsequent validation studies and was clearly evidenced by Mahieu et al. 3 Acute phase protein measurement (such as C-reactive protein, and other cytokines) was commonly used for diagnosis of LNS in many neonatal care settings; however, the utility of such tests in decision-making is limited by test performance, availability, and turn-around time. 19, 20 Our prediction score does show significant overlapping with other prediction scores especially the NOSEP score. 3 Although our results overlapped with this study, we had derived the score using larger sample size and also including more general infants. As the result of this, external generalization might be more feasible. We consider overlapping to be a normal phenomenon; the reason being that the systematic scoring rule development requires the same procedures in choosing potential predictors. 21 These procedures include thorough literature reviews to identify possible risk factors, testing with bivariate analysis, and clinical judgments.
CONCLUSIONS
We proposed a prediction-scoring model for LNS that was composed of simple clinical variables, basic laboratory findings, and common management, which should therefore be practical in most situations including bedside practice and resource-poor settings. The model well predicted proven LNS in our study setting; its validation in other settings is needed.
